Filing Details
- Accession Number:
- 0001062993-23-013263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-09 16:07:56
- Reporting Period:
- 2023-06-07
- Accepted Time:
- 2023-06-09 16:07:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534980 | R. Charles Kummeth | 614 Mckinley Place Ne Minneapolis MN 55413 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-06-07 | 322 | $83.00 | 1,112,817 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 400 | Indirect | By Step-Son |
| Common Stock | 400 | Indirect | By Step-Daughter |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | $26.65 | 2023-08-18 | 616,676 | 616,676 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $31.26 | 2024-08-09 | 779,084 | 779,084 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $44.33 | 2025-08-08 | 361,336 | 361,336 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $44.33 | 2025-08-08 | 240,888 | 240,888 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $47.60 | 2026-08-07 | 342,900 | 342,900 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 52,900 | 52,900 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $47.60 | 2026-08-07 | 228,600 | 228,600 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 51,516 | 51,516 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $66.97 | 2027-08-05 | 299,768 | 299,768 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $66.97 | 2027-08-05 | 153,180 | 153,180 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $66.97 | 2027-08-05 | 66,600 | 66,600 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $66.97 | 2027-08-05 | 66,600 | 66,600 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 32,064 | 32,064 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $120.46 | 2028-08-06 | 125,260 | 125,260 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $120.46 | 2028-08-06 | 83,504 | 83,504 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $94.52 | 2029-08-15 | 1,200,000 | 1,200,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-08-18 | 616,676 | 616,676 | Direct |
| 2024-08-09 | 779,084 | 779,084 | Direct |
| 2025-08-08 | 361,336 | 361,336 | Direct |
| 2025-08-08 | 240,888 | 240,888 | Direct |
| 2026-08-07 | 342,900 | 342,900 | Direct |
| 52,900 | 52,900 | Direct | |
| 2026-08-07 | 228,600 | 228,600 | Direct |
| 51,516 | 51,516 | Direct | |
| 2027-08-05 | 299,768 | 299,768 | Direct |
| 2027-08-05 | 153,180 | 153,180 | Direct |
| 2027-08-05 | 66,600 | 66,600 | Direct |
| 2027-08-05 | 66,600 | 66,600 | Direct |
| 32,064 | 32,064 | Direct | |
| 2028-08-06 | 125,260 | 125,260 | Direct |
| 2028-08-06 | 83,504 | 83,504 | Direct |
| 2029-08-15 | 1,200,000 | 1,200,000 | Direct |
Footnotes
- Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024.
- Fully exercisable.
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- 17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024.
- Options to purchase 57,152 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 57,148 shares vest on each of 8/7/2022 and 8/7/2023.
- Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
- Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
- Options to purchase 22,200 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
- Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
- 600,000 options vest in full or in part on 7/1/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator), and 600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Billionaire Hedge Funds
